Company intelligence

CALC

CalciMedica, Inc. · NASDAQ · Healthcare

Price$0.59+5.68% · +$0.03

Market cap9.26MEquity value

P / E-0.4Trailing ratio

Volume217.75KLatest session

Market data

CALC price chart

TradingView

Related signals

1 min delayed

Browse public CALC signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CALCJan 28, 2026-11.30% since signal

CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis

CalciMedica, Inc. (NASDAQ: CALC) shares have dipped following the abrupt discontinuation of its Phase 2 KOURAGE clinical trial, signaling potential setbacks in drug development. This decision may erode investor confidence and have long-term implications for the company's market position and growth trajectory.

View signal analysis

Research